MedTrace Logo

Accelerating Access and Improving Imaging in Heart Failure Care (A2I2HF) Pilot Study

NCT07624565 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2026-06-03

No results posted yet for this study

Summary

This is a prospective, multicenter, cluster randomised trial which will assess the feasibility and acceptability of AI-assisted point of care echocardiography on HF detection and downstream care processes for patients with suspected HF discharged from the Emergency Department.

Conditions

Interventions

DEVICE

AI-assisted point-of-care ultrasound (POCUS)

ED physicians at both sites will be provided with 1 session of in person training in the use of the AI-assisted POCUS device within 4 weeks of randomization including, * Device set up * Demo of patient exam with POCUS device (to be used within its CE/Health Canada marked intended purpose or where deemed clinically appropriate by the treating physician). * Generation of AI-automated echocardiogram report for LVEF and diastolic dysfunction.

Sponsors & Collaborators

Principal Investigators

  • Safia Chatur, MD · Massachusetts General Hospital/Harvard Medical School and University of Alberta

  • Justin Ezekowitz, MD · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-25
Primary Completion
2027-08-15
Completion
2028-08-14

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07624565 on ClinicalTrials.gov